Skip to Main Content

Yale Medical Oncology-Hematology Program

2018 Fellows Welcome Party

The Yale Medical Oncology-Hematology Fellowship Program is a 36-month training program that adheres to the ACGME and ABIM guidelines for combined training in Medical Oncology and Hematology. The fellowship program provides comprehensive clinical training in the diagnosis and management of neoplastic and benign hematologic disorders and a robust research experience to prepare fellows for a career in academic medicine. Fellows have the opportunity to train in multiple health care settings and to care for a diverse patient population with respect to gender and socio-economic backgrounds.


The goal of the Yale Medical Oncology-Hematology Fellowship Program is to train the next generation of academic hematologists and oncologists devoted to laboratory-based or patient-oriented investigation. Thus, the program is designed and structured to provide not only comprehensive clinical training but also a rigorous research experience to prepare fellows for careers as clinician investigators or clinician scientists in academic medicine.


Fellows will complete 18 months of full time clinical training dedicated to the acquisition of the medical knowledge, clinical skills, and competence to practice Medical Oncology and Hematology. All fellows are required to engage in 18 months of research (clinical, translational, or basic science) under the mentorship of Yale Cancer Center faculty.  In addition, fellows will complete 36 months of a continuity clinic in six blocks of six months duration, ½ - 1 day per week, which include a general oncology clinic at the West Haven VA and at least five disease-specific clinics at Smilow Cancer Hospital at Yale-New Haven.

In recognition of the increasing complexity of cancer therapy, particularly with respect to the interface between laboratory discovery and clinical care, the fellowship training has been organized to provide experience in the multidisciplinary care of patients, supplemented by an intensive program of didactic lectures, inter-disciplinary tumor boards, research seminars, and formal coursework. The outpatient clinics are structured according to specific diseases (e.g., breast cancer, lymphoma, lung cancer, benign hematologic disease, etc). Each disease-specific unit is supported by a weekly inter-disciplinary tumor board attended by specialized faculty members from other departments, where patients are discussed in depth with review of pathologic and radiological data. The disease-specific units facilitate the clinical and translation research programs at Yale and improve patient care by consolidating complex and inter-disciplinary management.

Program Leadership and Adminisration

Dr. Roy Herbst and Dr. Charles Fuchs are the Chief and Interim Chief of the Section of Medical Oncology and the Section of Hematology, respectively. Dr. Jill Lacy is the Director of the Medical Oncology-Hematology Fellowship Training Program. Dr. Nikolai Podoltsev is the Associate Program Director for Hematology and Dr. Michael Hurwitz is the Associate Program Director for Research. Dr. Michal Rose is the local on-site director of fellowship activities at the VA CT Healthcare System of West Haven, where she is also the Chief of the Section of Hematology-Oncology and Cancer Center Director. The Fellowship Administrator and Coordinator is Lucilina Gilkes.

Program Details